Vitamin B9 — essential for DNA synthesis and cell division. But folic acid, folate, and L-methylfolate are not the same thing, and for up to 40% of people, the difference matters enormously.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.
Folate (Vitamin B9) is a water-soluble B vitamin that plays a central role in DNA synthesis and repair, cell division, and the production of red and white blood cells. Because it's essential for rapid cell division, the need for folate is dramatically elevated during periods of fast growth — particularly in early fetal development and pregnancy.
Folate is found naturally in dark leafy greens (spinach, asparagus, Brussels sprouts), legumes, eggs, and citrus fruits. Most people can meet their needs through diet, though certain groups — pregnant women, people on specific medications, and those with the MTHFR gene variant — have elevated requirements or impaired conversion.
The term "folate" refers to the naturally occurring form. "Folic acid" is the synthetic, oxidized form used in most supplements and food fortification. They sound interchangeable — but biologically, they aren't, and this distinction has real consequences for a significant portion of the population.
Before your body can use any form of Vitamin B9, it must be converted into the active form: 5-methyltetrahydrofolate (5-MTHF), also called L-methylfolate. This conversion requires an enzyme called MTHFR (methylenetetrahydrofolate reductase).
Here's the problem: an estimated 40% of the population carries a common variant (polymorphism) in the MTHFR gene that reduces this enzyme's activity by 20–70%. For these people, standard folic acid supplementation doesn't work nearly as well — the body can't convert it efficiently enough to raise active folate levels.
MTHFR gene variants are among the most common genetic polymorphisms in humans. The two most studied are C677T and A1298C. Having one or two copies of these variants (heterozygous or homozygous) reduces MTHFR enzyme activity and therefore the ability to convert folic acid into usable folate.
Given the ~40% prevalence of MTHFR variants and the fact that L-methylfolate works for everyone regardless of gene status, choosing L-methylfolate over folic acid is a reasonable default — especially for anyone planning a pregnancy.
Note: 1 mcg of L-methylfolate = 1 mcg DFE. 1 mcg of synthetic folic acid from supplements = 1.7 mcg DFE (it's more bioavailable than food folate but still requires conversion). Most people eating a varied diet with leafy greens are close to adequate.
Neural tube formation occurs in the first 28 days of pregnancy — often before a woman knows she's pregnant. This is why folate supplementation should ideally begin at least one month before conception and continue through the first trimester.
Upper limit: 1,000 mcg/day of folic acid (not L-methylfolate). The concern is that high doses of folic acid can mask Vitamin B12 deficiency — a serious issue in older adults. L-methylfolate doesn't carry this same masking risk, which is another reason to prefer it over folic acid.
Folate in its natural food form or as L-methylfolate is very well tolerated. Folic acid at high doses carries more nuance.
High-dose folic acid can correct the megaloblastic anemia caused by B12 deficiency while the underlying neurological damage from B12 deficiency continues undetected. This is particularly dangerous in older adults who are at higher risk of B12 deficiency. Always ensure B12 status is adequate — especially if taking high-dose folic acid.
Methotrexate (used for cancer, rheumatoid arthritis, psoriasis) works by blocking folate metabolism. Supplementing folate while on methotrexate can reduce the drug's effectiveness — always discuss with your prescribing doctor. However, low-dose folate supplementation is sometimes prescribed alongside methotrexate to reduce side effects.
Several medications deplete folate or interfere with its metabolism: anticonvulsants (phenytoin, carbamazepine), trimethoprim (antibiotic), sulfasalazine, and some antidiabetic drugs. If you take any of these long-term, discuss folate supplementation with your doctor.
The landmark 1991 MRC randomised controlled trial demonstrated that periconceptional folic acid supplementation reduced neural tube defect recurrence by 72% — one of the most robust findings in nutritional science. Subsequent population-level data from mandatory folic acid fortification programmes confirm a 19–32% reduction in NTD births. Evidence is also strong for homocysteine lowering: the B6 + B12 + folate combination consistently lowers circulating homocysteine in multiple RCTs. A 2012 trial by Papakostas et al. found L-methylfolate as an adjunct to SSRI therapy produced meaningful improvement in treatment-resistant depression, particularly in patients with MTHFR variants.
1. MRC Vitamin Study Research Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. The Lancet, 338(8760), 131–137.
2. Papakostas GI et al. (2012). L-methylfolate as adjunctive therapy for SSRI-resistant major depression. Am J Psychiatry, 169(12), 1267–1274.
3. Clarke R et al. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol, 55(11), 1449–1455.
All references are peer-reviewed studies or position stands from reputable organizations.
Evidence-based supplement recommendations from a former physical store owner. No hype. No BS. Just facts.
Download Free PDF